That synopsis sounds reasonable to me. 2.5B A/S, but, no real evidence of heavy dilution. The kicker here *is* the contract for $20M yearly. Assuming there are no stipulations in the contract or constraints, then, it sounds like a fair valuation range.
Does anyone have the exact details of the contract? I have seen a dozen references but do not know any real specifics. Also, what will Eagle's takeaway be? Will all earnings be retained by the parent company?I will add this to my watch list. ; )